Becton Dickinson Group to introduce health care products

by Jayampathy JAYASINGHE

[email protected]
 

The Becton Dickinson Group of India in collaboration with A. Baur and Co.Ltd, plans to introduce innovative health care products in Sri Lanka.

A nine-member team from the Becton Dickinson Group, India was here recently to promote their range of medical products in Sri Lanka. Managing Director of Becton Dickinson of India, Rauff Sharma said the company manufactures a wide range of medical supplies, devices and laboratory equipment.

He said Becton Dickinson holds the leadership position globally in needles and syringes and was the largest manufacturer. "Around 20 million people globally were infected with hepatitis and with HIV by using unsafe needles", he said.

In response to questions posed by the media, Sharma said the product available in the United States was the identical product available in India and elsewhere. The quality of the product has not been compromised anywhere, he said.

Becton Dickinson's operations in Sri Lanka commenced about eight years ago with the first shipment of drugs to the State Pharmaceuticals Corporation (SPC). Since then Becton Dickinson had won the SPC Merit Award consecutively for three years - from 2005-2007.

Baur and Company's Director, Mahanama Dodampegama said they started working with Becton Dickinson eight years ago. "We have demonstrated to Becton Dickinson in developing technology and transferring them to the health care sector."

"When people visit private sector hospitals they will find that the latest innovative methods were used to draw blood from patients. We have done a lot in this area," he said. Meanwhile the Becton Dickinson Group India has selected Sri Lanka as a venue to host their management meeting.

Becton Dickinson is a global company that manufactures and sells medical devices, instruments and systems. Founded in 1897, the main office complex is in Franklin Lakes, New Jersey.

The company employs 28,000 people in 50 countries and serves health care institutions, science researchers, laboratories and the pharmaceutical industry.